SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-135477
Filing Date
2014-04-08
Accepted
2014-04-08 16:06:37
Documents
7
Period of Report
2014-05-20
Effectiveness Date
2014-04-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A d684508ddef14a.htm DEF 14A 262414
2 GRAPHIC g684508001.jpg GRAPHIC 5537
3 GRAPHIC g684508002.jpg GRAPHIC 15512
4 GRAPHIC g684508003.jpg GRAPHIC 16298
5 GRAPHIC g684508003a.jpg GRAPHIC 2604
6 GRAPHIC g684508pc1.jpg GRAPHIC 197404
7 GRAPHIC g684508pc2.jpg GRAPHIC 118661
  Complete submission text file 0001193125-14-135477.txt   754851
Mailing Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36075 | Film No.: 14751222
SIC: 2834 Pharmaceutical Preparations